Abstract | OBJECTIVE: METHODS: RESULTS: All three treatment groups showed significant decreases from baseline in serum levels of alanine aminotransferase, aspartate aminotransferase, HBV DNA, HA, LN, PCIV and PLD (all P < 0.05). However, the changes in HA, LN, PCIV and PLD levels were significantly greater in group A than in either group B or C (P < 0.05). All three treatment groups showed significant improvements from baseline in liver fibrosis grade and liver stiffness score (P < 0.05). The total effective rate of group A was 82.14%, which was significantly higher than that of groups B and C (P < 0.05). CONCLUSION:
|
Authors | Gang Wu, Hongyan He, Hua Li, Wen Chen |
Journal | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
(Zhonghua Gan Zang Bing Za Zhi)
Vol. 22
Issue 8
Pg. 604-8
(Aug 2014)
ISSN: 1007-3418 [Print] China |
PMID | 25243962
(Publication Type: Controlled Clinical Trial, English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Drugs, Chinese Herbal
- entecavir
- Guanine
|
Topics |
- Adult
- Aged
- Drug Therapy, Combination
- Drugs, Chinese Herbal
(therapeutic use)
- Female
- Guanine
(analogs & derivatives, therapeutic use)
- Hepatitis B virus
- Hepatitis B, Chronic
(drug therapy)
- Humans
- Liver Cirrhosis
(drug therapy, virology)
- Male
- Middle Aged
- Phytotherapy
|